3 recruiting, 1 not yet recruiting, 1 unknown, 1 withdrawn. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 3, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow HS-20093: new trials by email Literature Review of HS-20093 trials Research Report on HS-20093
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer HRS-2329 Tablet, Nimotuzumab, HS-20093 - Pancreatic Cancer, RAS Mutations or Amplifications | Phase 1 / Phase 2 | Not yet recruiting | Zhejiang University | 80 | 2026-08-15 | 2026-08-31 |
| ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer HS-20093 - Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 2 | Withdrawn | Hansoh BioMedical R&D Company | 2024-11-30 | 2024-03-04 | |
| HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors HS-20093 - Advanced Solid Tumor | Phase 2 | Recruiting | Hansoh BioMedical R&D Company | 220 | 2024-02-06 | 2024-12-02 |
| ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors HS-20093 - Metastasis Castration Resistant Prostate Cancer(mCRPC) | Phase 2 | Unknown | Hansoh BioMedical R&D Company | 120 | 2024-01-18 | 2024-08-20 |
| ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors HS-20093 - Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Hansoh BioMedical R&D Company | 170 | 2023-12-18 | 2024-08-20 |
| ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas HS-20093 - Osteosarcoma, Sarcoma | Phase 2 | Recruiting | Hansoh BioMedical R&D Company | 170 | 2023-06-08 | 2024-08-23 |
Esophageal Neoplasms (1) · Osteosarcoma (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Hansoh BioMedical R&D Company (5) · Zhejiang University (1)
China (5)
Wei Guo, MD (1)